Pear therapeutics to participate in citi's biotech c-suite virtual fireside chat series

Boston--( business wire )--pear therapeutics, inc. (nasdaq: pear), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (pdts), today announced the company will participate in citi's biotech c-suite virtual fireside chat series on tuesday, january 24 at 11:00 a.m. et. corey mccann, m.d., ph.d., president and ceo, will participate in the citi analyst-hosted fireside chat to discuss pear's progress on market access.
PEAR Ratings Summary
PEAR Quant Ranking